Nationwide Voluntary Field Correction Action Issued for GE Healthcare’s Giraffe Incubator and Giraffe OmniBed with Servo Oxygen Control System

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Nationwide Voluntary Field Correction Action Issued for GE Healthcare’s Giraffe Incubator and Giraffe OmniBed with Servo Oxygen Control System

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Nationwide Voluntary Field Correction Action Issued for GE Healthcare’s Giraffe Incubator and Giraffe OmniBed with Servo Oxygen Control System

04/23/2013 10:47 AM EDT

On January 8, 2013, GE Healthcare initiated a nationwide voluntary field corrective action of the Giraffe Incubator with a Servo Control Oxygen System and Giraffe OmniBed, which were manufactured from August 1, 2012 through December 20, 2012. Giraffe Incubators without a Servo Control Oxygen System are not impacted.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@xxxxxxxxxxxxxxx
• Other inquiries? webmail@xxxxxxxxxx

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420